EUVIMEDEUVIMED entdecken
Systematische ÜbersichtNetzwerk-MetaanalyseOpen Access · CC BY-NC 4.0

Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis

André L F Azeredo-da-Silva iD, Victor Hugo F de Jesus iD, Ion Agirrezabal iD, Victoria K Brennan iD, Phuong L Carion iD, Nathalie Amoury iD, Bruna M Vetromilla iD, Bruna S Zanotto iD, Suki Shergill iD, Patricia K Ziegelmann iD

Advances in Therapy · 2024-04 · 41 (4) · 1606-1620

DOI: 10.1007/s12325-024-02800-5 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Advances in Therapy, online erschienen am 26.02.2024. Verfasst von André L F Azeredo-da-Silva und 9 weiteren Autor:innen. Beteiligte Einrichtung: HTAnalyze Consultoria e Treinamento Ltda., Porto Alegre, RS, Brazil. andre@htanalyze.com. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Yttrium Radioisotopes, Microspheres. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Sirtex Medical.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: This literature review and exploratory network meta-analysis (NMA) aimed to compare the clinical effectiveness and tolerability of selective internal radiation therapy (SIRT) using yttrium-90 (Y-90) resin microspheres, regorafenib (REG), trifluridine-tipiracil (TFD/TPI), and best supportive care (BSC) in adult patients with chemotherapy-refractory or chemotherapy-intolerant metastatic colorectal cancer (mCRC). METHODS: In light of recently published data, the literature was searched to complement and update a review published in 2018. Studies up to December 2022 comparing two or more of the treatments and reporting overall survival (OS), progression-free survival (PFS), or incidence of adverse events (AE) were included. The NMA compared hazard ratios (HRs) for OS and PFS using Markov chain Monte Carlo techniques. RESULTS: Fifteen studies were included, with eight studies added (none addressing SIRT). All active treatments improved OS in relation to BSC. SIRT had the longest OS among all treatments, although without statistically significant differences (HR [95% credible interval] for SIRT, 0.48 [0.27, 0.87]; TFD/TPI, 0.62 [0.46, 0.83]; REG, 0.78 [0.57, 1.05]) in a fixed effects model. Information regarding SIRT was insufficient for PFS analysis, and TFD/TPI was the best intervention (HR 2.26 [1.6, 3.18]). One SIRT study reported radioembolization-induced liver disease in > 10% of the sample; this was symptomatically managed. Non-haematological AEs (hand-foot skin reaction, fatigue, diarrhoea, hypertension, rash or desquamation) were more common with REG, while haematological events (neutropoenia, leukopenia, and anaemia) were more common with TFD/TPI. CONCLUSION: Current evidence supports SIRT treatment in patients with chemotherapy-refractory or chemotherapy-intolerant mCRC compared to newer oral agents, with comparable OS and low incidence of AEs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colorectal NeoplasmsYttrium RadioisotopesMicrospheresHumansTrifluridineDrug CombinationsPhenylurea CompoundsBrachytherapyPyrrolidinesPyridinesThymine

Stichwörter der Autor:innen

Best supportiveLiver metastasisRegorafenibSIRTTrifluridine–tipiracil

Substanzen

Yttrium RadioisotopesYttrium-90TrifluridineregorafenibDrug Combinationstrifluridine tipiracil drug combinationPhenylurea CompoundsPyrrolidinesPyridinesThymine

Autor:innen und Institutionen

  • HTAnalyze Consultoria e Treinamento Ltda., Porto Alegre, RS, Brazil. andre@htanalyze.com.
  • , Av. General Flores da Cunha, 1050, sala 704, bairro Vila Veranópolis, RS, 94910001, Cachoeirinha, Brazil. andre@htanalyze.com.
  • Medical Oncology Department, Oncoclínicas Florianópolis, Florianópolis, SC, Brazil.
  • Sirtex Medical Europe GmbH, Bonn, Germany.
  • Sirtex Medical United Kingdom Ltd., Hill House, London, UK.
  • HTAnalyze Consultoria e Treinamento Ltda., Porto Alegre, RS, Brazil.

ORCID-Profile: André L F Azeredo-da-Silva, Victor Hugo F de Jesus, Ion Agirrezabal, Victoria K Brennan, Phuong L Carion, Nathalie Amoury, Bruna M Vetromilla, Bruna S Zanotto, Suki Shergill, Patricia K Ziegelmann

Förderung

  • Sirtex Medical

Zitieren

APA

Azeredo-da-Silva, A. L. F., de Jesus, V. H. F., Agirrezabal, I., Brennan, V. K., Carion, P. L., Amoury, N., Vetromilla, B. M., Zanotto, B. S., Shergill, S., & Ziegelmann, P. K. (2024). Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis. Advances in Therapy, 41(4), 1606-1620. https://doi.org/10.1007/s12325-024-02800-5

Vancouver

Azeredo-da-Silva ALF, de Jesus VHF, Agirrezabal I, Brennan VK, Carion PL, Amoury N, et al. Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis. Advances in Therapy. 2024;41(4):1606-1620. doi:10.1007/s12325-024-02800-5

BibTeX
@article{AzeredodaSilva2024,
  author = {Azeredo-da-Silva, André L F and de Jesus, Victor Hugo F and Agirrezabal, Ion and Brennan, Victoria K and Carion, Phuong L and Amoury, Nathalie and Vetromilla, Bruna M and Zanotto, Bruna S and Shergill, Suki and Ziegelmann, Patricia K},
  title = {Selective Internal Radiation Therapy Using Y-90 Resin Microspheres for Metastatic Colorectal Cancer: An Updated Systematic Review and Network Meta-Analysis},
  journal = {Advances in Therapy},
  year = {2024},
  volume = {41},
  number = {4},
  pages = {1606--1620},
  doi = {10.1007/s12325-024-02800-5}
}
Kostenlos starten →